Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis (Q40325513)
Jump to navigation
Jump to search
scientific article published on 24 January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis |
scientific article published on 24 January 2006 |
Statements
1 reference
Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis (English)
1 reference
Neil P Shah
1 reference
Francis Y Lee
1 reference
Roger Luo
1 reference
Yibin Jiang
1 reference
Marjolein Donker
1 reference
Cem Akin
1 reference
24 January 2006
1 reference
Identifiers
1 reference